Check out this morning’s top movers from around Wall Street, compiled by The Fly. Maximize Your Portfolio with Data Driven Insights:Leverage ...
Under the agreement, Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted for Auvelity, or on or after ...